3. What are the implications for future practice? Early diagnosis of this fatal complication can prevent inappropriate use of resources.
Background
Worldwide, hepatocellular carcinoma (HCC) is the fifth most common cancer and the third most common cause of cancer-related death. 1 HCC accounts for 1-2.5% of all cancer in America. More than 80% of HCC worldwide is attributable to the combined effects of chronic hepatitis B & C infections. 2, 3 Many paraneoplastic manifestations are documented with HCC. Yet advanced HCC with an invasion of the inferior vena cava is an uncommon way for the disease to progress and it is rare to see an extension of tumour thrombus in the right atrium of the heart.
4-6

Abstract
Vallakati et al have reported such extension in 1-4 % of HCC cases. 5 We report this relatively rare case of HCC with a Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality. Hepatitis B & C accounts for most HCC occurrences. It is very rare to see a tumour thrombus extending into the right atrium of the heart as a result of the invasion of HCC. This complication has a very poor prognosis as mean survival time is about three to four months. We encountered such a rare case of hepatocellular carcinoma having extensive tumour thrombus extending into the right atrium without any cardio respiratory distress or clinical finding suggestive of cardiovascular involvement. Key Words: Hepatocellular carcinoma; tumour thrombus Implications for Practice 1. What is known about this subject? Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world and an extension of tumour thrombus in the right atrium of the heart has been reported in 0.5-4 % of HCC cases. 2. What is the key finding in this case report? Asymptomatic presentation of extensive tumour thrombus extending from left portal vein, inferior vena cava to right atrium valve of heart at the time of diagnosis of HCC, an extremely rare situation which has very poor prognosis.
complication of the inferior vena cava (IVC) tumour thrombus extending into right atrium.
Case details
A 55-year-old male with history of chronic alcohol intake, presented with right upper abdominal pain, which had been present for more than three months. It was associated with low grade fever and weight loss. He did not have any prior history of surgery, blood transfusions or jaundice. At the time of presentation, his vital signs were normal and he did not have pallor, icterus or pedal oedema. On examination, moderate hepatomegaly was noted. The rest of the physical examination was unremarkable. Complete blood count, basic biochemistry investigations and coagulation studies were within normal limits. ESR was elevated (84 mm/hr). 
Discussion
Worldwide, HCC is the third most common cause of cancerrelated mortality and hepatitis B is considered as one of the leading cause for the HCC. HCC develops from chronic hepatitis B at the rate of 0.5% per year. 1 Our patient also had hepatitis B as the primary aetiology for development of HCC. We were unable to elicit a risk factor for hepatitis B from the patient which is a common scenario among patients from South Asia.
The most common paraneoplastic syndromes reported in HCC are biochemical abnormalities without associated clinical consequences. Tumour thrombus is a very rare complication observed with HCC. According to Kim et al, only 0.53% of HCC patients have invasion to the IVC. 7 An intra-atrial tumour thrombus is extremely rare in cases of HCC and is more commonly seen with malignancies of the kidney and adrenal glands. 7 Our patient presented with a huge tumour thrombus extending from the left portal vein, the IVC to the right atrium. Such an extensive thrombus on presentation is extremely rare.
Extension of the tumour thrombus to the IVC and/or right atrium is usually first disclosed at autopsy; there are only a few reported cases in which the intra-atrial growth could have been diagnosed by non-invasive radiology and echocardiography prior to death. 4, 5 Our patient was admitted with complaints of right upper abdominal pain, low grade fever and weight loss. He had no cardiorespiratory findings despite having such a large thrombus. The literature also states that right atrial thrombus may not cause any symptoms, but can sometimes lead to shock from ball valve obstruction of the tricuspid valve, right heart failure, pulmonary emboli and sudden death. 8, 9 The tumour thrombus and its extension was diagnosed on ultrasonography of abdomen and echocardiography and confirmed by CT in the reported case. Echocardiography has been shown to be a useful additional diagnostic step for detection of cardiac metastasis and other complications like thrombosis. Echocardiography can provide information not only about the size and extension of the thrombus, but also about the mobility of the tumour thrombus and the relation of the valve and cardiac muscle with respect to the thrombus. With the invention of better non-invasive diagnostic approaches such as CT, MRI, and trans-thoracic echocardiography (TTE), it is very easy to diagnose many such rare and deep-seated complications in the early stages even before they manifest as was the case with our patient.
Surgical resection, liver transplantation, non-surgical procedures such as radio frequency ablation, intra-arterial chemoembolisation and drugs such as thalidomide and sorafenib (multikinase inhibitor of the platelet derived growth factor) have been shown to be effective for relieving symptoms and prolonging life in HCC patients with multiple or extensive metastasis. However, very high mortality rates are observed for advanced HCC with IVC and intra-atrial tumour thrombus extension. Mean survival time reported is three to four months whether the patient is treated or not. 7 Hence aggressive therapy in patients with this rare and highly fatal complication is of little benefit due to their imminent, inevitable mortality. As many of our patients belong to lower socio-economical classes, screening for such asymptomatic but lethal complication can prevent inappropriate resource use and also can reduce discomfort to the patient of prolonged hospitalisation and aggressive treatment. Yet further data is required to generate more information on the balance of cost versus benefit for screening for this rare and fatal complication and what effect it would have on outcome. This information is important given the social and financial implications for often resource poor, affected, persons.
Conclusion
HCC patients are increasing in alarming numbers in the South-Asian subcontinent because of the increasing incidence of viral hepatitis B and C as well as alcoholinduced cirrhosis. We must remain vigilant about various uncommon manifestations associated with this carcinoma in our clinical practice which may be asymptomatic, as with our patient of HCC having intra-atrial tumour thrombus, this may influence the most appropriate treatment strategy.
